ORLANDO, FL – Orlando-based LensAR has raised $2 million of a targeted $7 million offering, according to a regulatory filing. The company is developing and commercializing laser and 3D imaging technology for refractive cataract surgery.
The company raised $7 million in equity in July 2010 and $7.1 million in August 2009.
Investors in the firm include Aisling Cpaital of New York, and MA-based Extera Partners.
Randy Frey, CEO, writes on the company Web site that “The LensAR approach is to bring the accuracy and precision of lasers into the operating room to replace blades and greatly reduce, if not eliminate, the need for ultrasound power to perform the majority of cataract removals.”
To date, according to the company, the LensAR laser system has been successfully used in well over a hundred eyes outside of the US, and is actively under review with the FDA for approval for use in the United States.
The company disclosed the latest raise in a filing with the U.S. Securities and Exchange Commission.
Contact Tech Journal South Editor and writer Allan Maurer: Allan at TechJournalSouth dot com.
TechJournal South is a TechMedia company. TechMedia presents the annual conferences:
SoutheastVentureConference: www.seventure.org
Internet Summit: www.internetsummit.com
Digital East: www.digitaleast.com
Digital Summit: www.digitalsummit.com
Related Stories:
- LensAR focuses in on $7M of $12M equity round
- Orlando medical device company AOI nabs $2.9M of $5.6M offering
- Orlando game developer startup Row Sham Bow rocks $1.5M
- Red Wolf seeks $3M to commercialize NC State biofuels tech
- Dilon Technologies nabs $875K of $1.5M offering for medical imaging devices
© 2011, TechJournal. All rights reserved.
Tags: financing, FL, laser 3D imaging for catarac surgery, LensAR, Orland, SEC
